Population Bio (PB) – a global leader in gene discovery announced, in support of World Rare Disease Day, its continued investment in its CNV Beacon® gene discovery platform which delivers new knowledge about rare diseases.

Population Diagnostics – a global leader in gene discovery for complex disease announced today that it is changing its corporate name to Population Bio.

Collaboration Announced Between Researchers at University of California Irvine and Population Diagnostics,
Inc. at Rare Disease Event in Southern California

The Parkinson's Institute and Clinical Center announced today that they, in partnership with Population Diagnostics, Inc., have discovered a number of new genes relevant to the cause of Parkinson's disease.

The innovative approach used for this study focuses first on genome-wide investigation of gene copy number variants (CNVs) followed by targeted sequencing of CNV-identified candidate genes.

Peer-Reviewed Findings Provide Medically Relevant Content for Early Detection Pre-symptomatic Diagnostics for Autism as well as New Insights into Drug Discovery

Study Demonstrates Potential of Population Diagnostics' Gene Discovery Platform